Kelly SG, Campbell TC, Hillman L, Said A, Lucey MR, Agarwal PD

Language: English
References: 22
Page: 395-401
PDF size: 163.59 Kb.

ABSTRACT

Introduction and aim. Utilization of palliative care services in patients dying of end-stage liver disease (ESLD) is understudied. We performed a retrospective review of palliative care services among patients with ESLD unsuitable for liver transplantation (LT) at a tertiary care center. Material and methods. Deceased ESLD patients considered unsuitable for LT from 2007-2012 were identified. Patients were excluded if they received a transplant, had an incomplete workup, were lost to follow up or whose condition improved so LT was not needed. Of the 1,175 patients reviewed, 116 met inclusion criteria. Results. Forty patients (34.4%) received an inpatient palliative care (PC) consultation and forty-one patients (35.3%) were referred directly to hospice. Thirty-three patients (28.4%) transitioned to comfort measures without PC consultation (median survival ‹ 1 day). The median interval between LT denial and PC consultation or hospice was 28 days. Median survival after PC consult or hospice referral was 15 days. In conclusion, in a single center retrospective review of ESLD patients, palliative care services, when utilized, were for care at the very end of life. Without consultation, aggressive interventions continued until hours before death. We propose that ESLD patients could benefit from PC consultation at time of LT evaluation or based on MELD scores.

REFERENCES

1. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120: 170-8.

2. Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001; 96: 2199-205.

3. Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol 2010; 22: 221-7.

4. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life". JAMA 2006; 295: 2168-76.

5. Boyd K, Kimbell B, Murray S, Iredale J. Living and dying well with end-stage liver disease: Time for palliative care? Hepatology 2012; 55: 1650-1.

6. Sanchez W, Talwalker JA. Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation. Gastroenterology Clinics of North America 2006; 35: 201-19.

7. Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clinical Gastroenterology and Hepatology 2014; 12: 692-8.

8. Walling AM, Asch SM, Lorenz KA, Wenger NS. Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization. Transplantation 2013; 95: 641-6.

9. Gade G, Venohr I, Conner D, McGrady K, Beane J, Richardson RH, Williams MP, et al. Impact of an inpatient palliative care team: a randomized control trial. J Palliative Medicine 2008; 11: 180-90.

10. Brumley R, Enguidanos S, Jamison P, Seitz R, Morgenstern N, Saito S, McIlwane J, et al. Increased satisfaction with care and lower costs: results of a randomized trial of inhome palliative care. J Am Geratrics Soc 2007; 55: 993- 1000.

11. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Internal Med 2004; 164: 83-91.

12. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30.

13. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J 2010; 363: 733-42.

14. Pantilat SZ, O'Riordan DL, Dibble SL, Landefeld CS. Hospital- Based Palliative Medicine Consultation: A Randomized Controlled Trial. Arch Internal Med 2010; 170: 2038-40.

15. Rocque GB, Campbell TC, Johnson SK, King J, Zander MR, Quale RM, Eickhoff JC, et al. A Quantitative Study of Triggered Palliative Care Consultation for Hospitalized Patients with Advanced Cancer Journal of Pain and Symptom Management, 2015. DOI: doi:10.1016/j.jpainsymman.2015.04.022.

16. Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E. Impact of Timing and Setting of Palliative Care Referral on Quality of End-of-Life Care in Cancer Patients. Cancer 2014; 120: 1743-9.

17. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. The utility of the model for end-stage liver disease score: A reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liv Transplant 2008; 14: 1100-6.

18. R., H.T., Smith MA, Bartels CM, Campbell TC, Yu M, K.A. J.H. Hospice Enrollment, Local Hospice Utilization Patterns, and Rehospitalization in Medicare Patients. J Palliative Med 2015; 18: 601-12.

19. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, Meier DE. Cost Savings Associated With US Hospital Palliative Care Consultation Programs. Arch Internal Med 2008; 168: 1783-90. DOI: 10.1001/ archinte.168.16.1783.

20. Kamath PS, Kim WR. The Model for End-Stage Liver Disease (MELD). Hepatology 2007; 45: 797-805.

21. Schwarze ML, Kehler JM, Campbell TC. Navigating High Risk Procedures with More than Just a Street Map. J Palliative Med 2013; 16: 1169-71.

22. Nabozny MJ, Kruser JM, Steffens NM, Brasel KJ, Campbell TC, Gaines ME, Schwarze ML. Constructing High-Stakes Surgical Decisions: It Is Better to Die Trying. Ann Surgery 2015. DOI: 10.1097/SLA.0000000000001081.